Suchita Pakkala is an Oncology physician affiliated with Emory University. OpenAlex indexes 50 publications with 1,364 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1365c Clifton Rd NE
3rd Floor
Atlanta, GA 303221013
Telephone
404-686-1000Registry record last updated 27 Jan 2008.
Clinical trials
- Phase II Study of Everolimus Beyond Progression
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Caris MPI, Inc.Program year20251 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
68.9%Aromatase Inhibitor43.3%Anastrozole54%Letrozole28%Exemestane19%Part D≥54 patientsKinase inhibitor17.9%Verzenio32%Kisqali25%Ibrance23%Tagrisso20%Part D<11 patients+ 1 more class in this area
Nervous system
18.4%Phenothiazine7.5%Prochlorperazine Maleate100%Part D≥29 patientsGabapentinoids5.1%Gabapentin100%Part D≥13 patients+ 2 more classes in this area
Metabolism & gastrointestinal
7.8%Opioid Agonist4.6%Loperamide100%Part D≥16 patientsSerotonin-3 Receptor Antagonist3.2%Ondansetron Hcl100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Guyton, MD
Emory University
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”